11.05

0.99% -0.11

Pre-market: 11.30 0.25 +2.26%

Enfusion Inc (ENFN)

Overview News Price History Option Chain Discussions Forecast

Enfusion Inc stock is traded at $11.05, with a volume of 1.16M. It is down -0.99% in the last 24 hours and down -0.90% over the past month. Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. The products and services that comprise its solution are designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa.

Previous Close:

$11.16

Open:

$11.17

24h Volume:

1.16M

Relative Volume:

1.21

Market Cap:

$1.05B

Revenue:

$174.54M

Net Income/Loss:

$6.03M

P/E Ratio:

138.12

EPS:

0.08

Net Cash Flow:

$15.96M

1W Performance:

-2.13%

1M Performance:

-0.90%

6M Performance:

+34.59%

1Y Performance:

+18.56%

1-Day Range:

$11.04

$11.17

1-Week Range:

$11.04

$11.32

52-Week Range:

$7.83

$11.80

Enfusion Inc Stock (ENFN) Company Profile

Name

Enfusion Inc

Sector

Technology (774)

Industry

Software - Application (271)

Phone

(312) 253-9800

Address

125 SOUTH CLARK STREET, SUITE 750, CHICAGO

Employee

1,143

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

ENFN's Discussions on Twitter

Compare ENFN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ENFN Enfusion Inc	11.05	1.05B	174.54M	6.03M	15.96M	0.08
SAP Sap Se Adr	255.19	297.70B	36.97B	3.37B	4.79B	2.8498
CRM Salesforce Inc	271.74	261.14B	37.90B	6.20B	12.43B	6.36
NOW Servicenow Inc	811.62	167.59B	10.98B	1.43B	3.38B	6.83
ADBE Adobe Inc	377.84	164.32B	21.51B	5.56B	7.87B	12.40
INTU Intuit Inc	581.32	162.51B	17.17B	3.04B	5.63B	10.72

Enfusion Inc Stock (ENFN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-10-24	Resumed	Morgan Stanley	Overweight
Feb-28-24	Downgrade	Goldman	Neutral → Sell
Jan-30-24	Downgrade	JP Morgan	Neutral → Underweight
Nov-07-23	Initiated	UBS	Neutral
Apr-03-23	Initiated	Piper Sandler	Neutral
Mar-15-23	Initiated	JP Morgan	Neutral
Jan-04-23	Downgrade	BofA Securities	Neutral → Underperform
Jan-03-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-03-22	Downgrade	BofA Securities	Buy → Neutral
Nov-15-21	Initiated	BofA Securities	Buy
Nov-15-21	Initiated	Credit Suisse	Neutral
Nov-15-21	Initiated	Goldman	Neutral
Nov-15-21	Initiated	Morgan Stanley	Equal-Weight
Nov-15-21	Initiated	Piper Sandler	Overweight
Nov-15-21	Initiated	Stifel	Buy
Nov-15-21	Initiated	William Blair	Outperform

View All

Enfusion Inc Stock (ENFN) Latest News

Mar 09, 2025

Enfusion, Inc. Reports Strong Growth Amid Acquisition Plans - MSN

Mar 09, 2025

Enfusion (ENFN) to Release Earnings on Tuesday - Defense World

Mar 09, 2025

Mar 08, 2025

Enfusion CEO Oleg Movchan sells $130,472 in stock By Investing.com - Investing.com South Africa

Mar 08, 2025

Rhumbline Advisers Has $643,000 Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World

Mar 08, 2025

Enfusion CFO sells $52,836 in stock to cover tax obligations By Investing.com - Investing.com Canada

Mar 08, 2025

Mar 07, 2025

Enfusion Executives Cash In: Major Stock Sales Unveiled! - TipRanks

Mar 07, 2025

Enfusion chief accounting officer sells $6,165 in stock By Investing.com - Investing.com Canada

Mar 07, 2025

Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock - Investing.com

Mar 07, 2025

Enfusion chief accounting officer sells $6,165 in stock - Investing.com

Mar 07, 2025

Enfusion COO Neal Pawar sells $165,620 in stock - Investing.com

Mar 07, 2025

Enfusion CFO sells $52,836 in stock to cover tax obligations - Investing.com India

Mar 07, 2025

Enfusion’s chief people officer sells shares worth $35,558 By Investing.com - Investing.com South Africa

Mar 07, 2025

Enfusion’s chief people officer sells shares worth $35,558 - Investing.com India

Mar 07, 2025

Enfusion Executives Sell Shares to Cover Tax Obligations - TradingView

Mar 07, 2025

Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock By Investing.com - Investing.com UK

Mar 07, 2025

Enfusion’s Hold Rating: Balancing Strategic Merger Benefits with Market Uncertainties - TipRanks

Mar 07, 2025

Mar 06, 2025

Enfusion’s CAO Makes a Noteworthy Stock Sale! - TipRanks

Mar 06, 2025

Enfusion’s general counsel sells $12,410 in stock to cover taxes By Investing.com - Investing.com South Africa

Mar 06, 2025

Enfusion Executives Unload Major Stock Holdings! - TipRanks

Mar 06, 2025

Mar 05, 2025

Enfusion COO Neal Pawar sells $31,790 in stock By Investing.com - Investing.com Canada

Mar 05, 2025

Enfusion chief accounting officer sells $2,514 in stock - Investing.com Australia

Mar 05, 2025

Enfusion chief accounting officer sells $2,514 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025

Enfusion CEO Oleg Movchan sells $32,031 in stock By Investing.com - Investing.com Canada

Mar 05, 2025

Enfusion CFO Bradley Herring sells $17,600 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025

Enfusion CEO Oleg Movchan sells $32,031 in stock - Investing.com India

Mar 05, 2025

Enfusion’s chief people officer sells shares worth $23,696 - Investing.com India

Mar 05, 2025

Enfusion CFO Bradley Herring sells $17,600 in stock - Investing.com

Mar 05, 2025

Enfusion COO Neal Pawar sells $31,790 in stock - Investing.com

Mar 05, 2025

Enfusion’s chief people officer sells shares worth $23,696 By Investing.com - Investing.com South Africa

Mar 05, 2025

Enfusion’s general counsel sells $12,410 in stock to cover taxes - Investing.com

Mar 05, 2025

Mar 04, 2025

Stifel maintains Enfusion stock Hold rating, $11.25 target By Investing.com - Investing.com Canada

Mar 04, 2025

Stifel maintains Enfusion stock Hold rating, $11.25 target - Investing.com India

Mar 04, 2025